Sunrest Lifescience Ltd. (SUNREST.NS)

Sunrest Lifescience Ltd. (SUNREST.NS) — VMCI valuation read

Across 120 indicators, Sunrest Lifescience Ltd. (SUNREST.NS) lands at VMCI 24/100. The Healthcare sector median is 50, so the 26-point below-median read is the active comparison. Pillar weighting on the score: Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%.

No material Form 4 disclosures landed on SUNREST.NS in the past 30 days. Quiet insider tape removes one signal source; the active reads stay with the trailing-twelve-month financials and the next 10-Q.

**Investor frame.** On Value, SUNREST.NS trades at 23.0x earnings, 28% above the Healthcare median of 18.0x; the EV/EBITDA delta of -2.0x reinforces that single line. On Quality, ROIC of 13.0% sits 3.0pp above the Healthcare median (10.0%). On Risk, net debt to EBITDA of -2.3x leaves covenant headroom for SUNREST.NS on the trailing balance sheet.

SUNREST.NS fell 3.6% over the trailing 7 days, with a -7.0% read on a 30-day basis.